The idea of adding cannabis to your investment portfolio may seem far-fetched. But this once frowned-upon commodity is fast becoming a viable asset for long-term sustainable wealth creation.
The demand for cannabis as a medical treatment is growing rapidly, and the Centre for Medicinal Cannabis (CMC) predicts that by 2024, the UK medical cannabis market alone will be worth close to £1bn ($1.3bn) and servicing nearly 340,000 active patients. And that is just the tip of the iceberg. Changes to UK legislation saw cannabis being legalised for medical use in November 2018. This is based on case studies showing that cannabinoids such as cannabidiol (CBD) and tetrahydrocannabinol (THC) are extremely effective at treating many physical, emotional and mental conditions, without the s...
To continue reading this article...
Join Investment Week for free
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes